4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-052610
Director bought 154 shares at an average $1.66 ($256)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young Caroline Director | 2024-12-02 | Purchase 10b5-1 | +15 | $1.33 | $20 | 29,679 | D |
| Young Caroline Director | 2024-12-03 | Purchase 10b5-1 | +15 | $1.26 | $19 | 29,694 | D |
| Young Caroline Director | 2024-12-04 | Purchase 10b5-1 | +15 | $1.22 | $18 | 29,709 | D |
| Young Caroline Director | 2024-12-05 | Purchase 10b5-1 | +15 | $1.20 | $18 | 29,724 | D |
| Young Caroline Director | 2024-12-06 | Purchase 10b5-1 | +15 | $1.20 | $18 | 29,739 | D |
| Young Caroline Director | 2024-12-09 | Purchase 10b5-1 | +15 | $1.25 | $19 | 29,754 | D |
| Young Caroline Director | 2024-12-10 | Purchase 10b5-1 | +7 | $2.48 | $17 | 29,761 | D |
| Young Caroline Director | 2024-12-11 | Purchase 10b5-1 | +7 | $2.29 | $16 | 29,768 | D |
| Young Caroline Director | 2024-12-12 | Purchase 10b5-1 | +7 | $2.19 | $15 | 29,775 | D |
| Young Caroline Director | 2024-12-13 | Purchase 10b5-1 | +7 | $2.33 | $16 | 29,782 | D |
| Young Caroline Director | 2024-12-16 | Purchase 10b5-1 | +10 | $2.21 | $22 | 29,792 | D |
| Young Caroline Director | 2024-12-17 | Purchase 10b5-1 | +10 | $2.12 | $21 | 29,802 | D |
| Young Caroline Director | 2024-12-18 | Purchase 10b5-1 | +10 | $2.19 | $22 | 29,812 | D |
| Young Caroline Director | 2024-12-19 | Purchase 10b5-1 | +4 | $2.33 | $9 | 29,816 | D |
| Young Caroline Director | 2024-12-20 | Purchase 10b5-1 | +2 | $2.35 | $5 | 29,818 | D |
| Open-market purchases · 154 sh · avg $1.66 · $256 | |||||||
Loading xslF345X05/wk-form4_1735606056.xml…